Connection

J. THORNTON to Humans

This is a "connection" page, showing publications J. THORNTON has written about Humans.
Connection Strength

0.499
  1. Concurrent Depression Management in Patients with Opioid Use Disorder Undergoing Buprenorphine Therapy: Association with Buprenorphine Discontinuation. J Dual Diagn. 2025 Apr; 21(2):142-151.
    View in: PubMed
    Score: 0.026
  2. Understanding the financial barriers to treatment among individuals with opioid use disorder: a focus group study. Harm Reduct J. 2024 Dec 20; 21(1):220.
    View in: PubMed
    Score: 0.026
  3. Characterising incident opioid use among incident users of prescription sedative hypnotics: A national cohort study. BMJ Open. 2024 05 30; 14(5):e082339.
    View in: PubMed
    Score: 0.025
  4. Patients' willingness to pay for naloxone: A national cross-sectional survey of prescription opioid users with chronic pain in the United States. J Am Pharm Assoc (2003). 2024 May-Jun; 64(3):102062.
    View in: PubMed
    Score: 0.024
  5. Productivity Loss Among Opioid and Benzodiazepine Users in the United States: A Medical Expenditure Panel Survey From 2010 to 2019. J Occup Environ Med. 2024 03 01; 66(3):226-233.
    View in: PubMed
    Score: 0.024
  6. Physician perspective on the implementation of risk mitigation strategies when prescribing opioid medications: a qualitative analysis. BMC Health Serv Res. 2023 Oct 31; 23(1):1185.
    View in: PubMed
    Score: 0.024
  7. Differences in Perceived Threat and Efficacy in Managing Opioid Use Disorder versus Alcohol Use Disorder. Subst Use Misuse. 2023; 58(10):1187-1195.
    View in: PubMed
    Score: 0.023
  8. Parents' intention to have their child vaccinated at a community pharmacy: A national cross-sectional survey. J Am Pharm Assoc (2003). 2023 Mar-Apr; 63(2):511-517.e8.
    View in: PubMed
    Score: 0.022
  9. Intention to get naloxone among?patients prescribed opioids for chronic pain. Harm Reduct J. 2022 Sep 22; 19(1):104.
    View in: PubMed
    Score: 0.022
  10. Comparing Two Databases to Identify Access to Buprenorphine Treatment for Opioid Use Disorder. J Pain Palliat Care Pharmacother. 2022 Jun; 36(2):103-111.
    View in: PubMed
    Score: 0.022
  11. Association of cash payment with intensity of opioid prescriptions. J Am Pharm Assoc (2003). 2022 Jul-Aug; 62(4):1224-1231.e5.
    View in: PubMed
    Score: 0.021
  12. Factors associated with the use of the prescription monitoring program by prescribers and pharmacists in Texas. Pharmacoepidemiol Drug Saf. 2021 04; 30(4):492-503.
    View in: PubMed
    Score: 0.020
  13. Impact of COVID-19 Related Policy Changes on Buprenorphine Dispensing in Texas. J Addict Med. 2020 12; 14(6):e372-e374.
    View in: PubMed
    Score: 0.020
  14. Does Social Desirability Influence Preceptors' Completion of Student Experiential Evaluations? Am J Pharm Educ. 2020 09; 84(9):ajpe7949.
    View in: PubMed
    Score: 0.019
  15. Applying the capability, opportunity, motivation, and behavior model to identify opportunities to increase pharmacist comfort dispensing naloxone in Texas: A structural equation modeling approach. Int J Drug Policy. 2020 09; 83:102827.
    View in: PubMed
    Score: 0.019
  16. Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications. Res Social Adm Pharm. 2021 01; 17(1):2005-2008.
    View in: PubMed
    Score: 0.019
  17. Prescription drug disposal: Products available for home use. J Am Pharm Assoc (2003). 2020 Jul - Aug; 60(4):e7-e13.
    View in: PubMed
    Score: 0.018
  18. Health-related quality of life in patients receiving long-term opioid therapy: a systematic review with meta-analysis. Qual Life Res. 2017 08; 26(8):1955-1967.
    View in: PubMed
    Score: 0.015
  19. Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia. J Am Pharm Assoc (2003). 2017 Mar - Apr; 57(2S):S12-S18.e4.
    View in: PubMed
    Score: 0.015
  20. Car Seat Safety: Typologies of Protective Health and Safety Behaviors for Mothers in West Virginia. Matern Child Health J. 2017 02; 21(2):326-334.
    View in: PubMed
    Score: 0.015
  21. Re: Saunders R, Lian J, Karolicki B, Valentine W. The cost-effectiveness and budget impact of stepwise addition of bolus insulin in the treatment of type 2 diabetes: evaluation of the FullSTEP trial. J Med Econ 2014;17(12):827-36. J Med Econ. 2015 Jun; 18(6):433-4.
    View in: PubMed
    Score: 0.013
  22. Impact of automated alerts on discharge opioid overprescribing after general surgery. Am J Health Syst Pharm. 2024 Dec 05; 81(24):1288-1296.
    View in: PubMed
    Score: 0.006
  23. Marginal health care expenditures for melanoma care in the United States. J Manag Care Spec Pharm. 2024 Dec; 30(12):1364-1374.
    View in: PubMed
    Score: 0.006
  24. Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas: Implications for Policy and Interventions in the Era of Immune Checkpoint Inhibitors. Am J Clin Oncol. 2024 Nov 01; 47(11):517-525.
    View in: PubMed
    Score: 0.006
  25. Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United States. Oncologist. 2024 Feb 02; 29(2):176-184.
    View in: PubMed
    Score: 0.006
  26. Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors. BMC Cancer. 2023 Jul 13; 23(1):655.
    View in: PubMed
    Score: 0.006
  27. Identifying predictors of generalized anxiety among student pharmacists in response to the COVID-19 pandemic. Curr Pharm Teach Learn. 2023 01; 15(1):34-42.
    View in: PubMed
    Score: 0.006
  28. Optimization of Opioid Discharge Prescriptions Following Thyroid and Parathyroid Surgery. Otolaryngol Head Neck Surg. 2023 Jul; 169(1):176-184.
    View in: PubMed
    Score: 0.006
  29. Trends and patterns in the use of opioids among metastatic breast cancer patients. Sci Rep. 2020 12 10; 10(1):21698.
    View in: PubMed
    Score: 0.005
  30. Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records. Mult Scler Relat Disord. 2020 Oct; 45:102334.
    View in: PubMed
    Score: 0.005
  31. Prolonged Opioid Use After Surgery for Early-Stage Breast Cancer. Oncologist. 2020 10; 25(10):e1574-e1582.
    View in: PubMed
    Score: 0.005
  32. Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015. J Manag Care Spec Pharm. 2020 Jun; 26(6):741-749.
    View in: PubMed
    Score: 0.005
  33. Prescribers' perceptions on the impact of hydrocodone rescheduling on geriatric pain management: A qualitative study. J Opioid Manag. 2018 Sep/Oct; 14(5):317-326.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.